Gregory R. Ott, Media US
Gregory R. Ott, Media, PA US
Patent application number | Description | Published |
---|---|---|
20090221555 | FUSED BICYCLIC DERIVATIVES OF 2,4-DIAMINOPYRIMIDINE AS ALK AND c-MET INHIBITORS - The present invention provides a compound of formula I or II or a pharmaceutically acceptable salt form thereof, wherein R | 09-03-2009 |
20120028919 | PYRROLOTRIAZINES AS ALK AND JAK2 INHIBITORS - The present invention provides a compound of formula I | 02-02-2012 |
20120165519 | Fused Bicyclic Derivatives of 2,4-Diaminopyrimidine as ALK and c-MET Inhibitors - The present invention provides a compound of formula I or II | 06-28-2012 |
20140031351 | Macrocyclic Compounds as ALK, FAK and JAK2 Inhibitors - The present invention provides compounds of Formula I | 01-30-2014 |
20140113882 | Azaquinazoline Inhibitors of Atypical Protein Kinase C - The present application provides a compound of formula (I) | 04-24-2014 |
20140323435 | Thienopyrimidine Inhibitors of Atypical Protein Kinase C - The present application provides a compound of formula (I) | 10-30-2014 |
20140350011 | Imidazo[4,5-b]pyridine Derivatives as ALK and JAK Modulators for the Treatment of Proliferative Disorders - This application relates to compounds of the Formula I | 11-27-2014 |
20150274720 | Azaquinazoline Inhibitors Of Atypical Protein Kinase C - The present application provides a compound of formula (I) | 10-01-2015 |